Your A1C result comes back from the lab as a percentage. Your glucose meter shows numbers in mg/dL. Your CGM app reports an average. None of these three numbers look the same, yet they all describe the same thing — your average blood sugar over the past two to three months. An A1C calculator bridges that gap instantly. Enter your A1C percentage and you get your estimated average glucose in mg/dL or mmol/L. Enter your average glucose and you get your estimated A1C. The result also tells you exactly which ADA category you fall into, what it means, and what to do next.

This guide covers the validated formula behind the conversion, what the ADA 2026 diagnostic categories mean in plain English, worked examples across four real patient scenarios, and the most common mistakes people make when interpreting A1C results. Whether you have just received your first A1C lab report or you are a diabetes patient tracking quarterly numbers, this calculator gives you the full picture in seconds.

What Is an A1C Calculator and Why Does It Matter

An A1C calculator converts between hemoglobin A1C percentage and estimated average glucose using the ADA-validated ADAG formula, and classifies the result against current ADA diagnostic thresholds for normal, prediabetes, and diabetes. People with diabetes or prediabetes, their family members, primary care physicians, nurses, diabetes educators, and anyone who has received an A1C lab result all use it to translate the clinical percentage into the everyday blood sugar units they recognize from a glucose meter. The core formula is: eAG (mg/dL) equals (28.7 multiplied by A1C%) minus 46.7. Getting this translation right matters because a lab report showing 7.2% is meaningless to most patients without context — knowing that 7.2% equals approximately 160 mg/dL average blood sugar, and that the ADA general target is below 7.0% (154 mg/dL), makes the result immediately actionable.

What You Need Before You Start

Have the following ready before using the A1C calculator:

- Your A1C percentage from a recent lab result — use the number exactly as reported on your lab slip. A1C is reported in NGSP percent (%) format in the United States. If your result is in IFCC units (mmol/mol), used in the UK and Europe, the calculator can convert that as well.

- Your preferred glucose unit — mg/dL (used in the US) or mmol/L (used in the UK, Canada, and most of the world). The calculator outputs both, but knowing your preference helps you interpret the result.

- Your age group if you want a personalized target interpretation — the ADA 2026 Standards of Care recommend different A1C targets for adults under 40, adults 40 to 64, adults 65 and older, and pregnant women.

- Your most recent prior A1C if you want a trend comparison — knowing whether your A1C has gone up, down, or stayed the same since last quarter is often as important as the current number itself.

- Whether you have any condition that affects red blood cell lifespan — iron deficiency anemia, hemolytic anemia, sickle cell trait, thalassemia, or recent blood transfusion can all cause A1C to read inaccurately. If any of these apply, note it before interpreting the result.

How to Use This A1C Calculator Step by Step

Enter your values in order for an instant conversion and clinical interpretation.

1. Select your conversion direction — A1C to eAG (you have a lab percentage and want average glucose) or eAG to A1C (you have a CGM average and want an estimated A1C).

2. Enter your A1C percentage — type the number exactly as it appears on your lab report, for example 6.5 or 8.2. Do not round to the nearest whole number.

3. Select your preferred output unit — mg/dL for US-standard results or mmol/L for international format. The calculator shows both automatically.

4. Select your age group for personalized ADA 2026 target guidance — under 40, 40 to 64, 65 and older, or pregnant.

5. Click Calculate. Your result shows the converted glucose value in both units, your ADA 2026 diagnostic category, your personal target range, and a plain-English interpretation of what the number means and what to do next.

6. Compare your result to your previous A1C if available — a drop of 0.5 percentage points or more in a quarter typically reflects a meaningful improvement in blood sugar control.

7. Share the result with your provider at your next appointment — the calculator output is a starting point for a clinical conversation, not a standalone treatment decision.

The A1C Calculator Formula Explained Simply

A1C measures the percentage of hemoglobin in your red blood cells that has glucose attached to it. Red blood cells live approximately 90 to 120 days, so the A1C reflects a rolling average of your blood sugar over that period — recent weeks weighted more heavily than earlier months because newer cells dominate the sample. The ADAG formula converts that percentage into the same units your glucose meter uses, making the two measurements directly comparable.

Core Formula — A1C to eAG:

eAG (mg/dL) = (28.7 x A1C%) - 46.7

Core Formula — eAG to A1C:

A1C% = (eAG + 46.7) / 28.7

Unit Conversion — mg/dL to mmol/L:

mmol/L = mg/dL / 18.0182

Unit Conversion — mmol/L to mg/dL:

mg/dL = mmol/L x 18.0182

IFCC to NGSP Conversion (international to US format):

NGSP% = (0.0915 x IFCC mmol/mol) + 2.15

- A1C%: the percentage of glycated hemoglobin reported by a certified laboratory. Realistic clinical range: 4.0% (extremely low) to 15.0% (severely elevated).

- eAG (mg/dL): estimated average glucose in US units. Realistic clinical range: 68 mg/dL (A1C 4%) to 355 mg/dL (A1C 14%).

- eAG (mmol/L): the same value in international units. Range: 3.8 to 19.7 mmol/L.

- 28.7: the slope of the linear regression derived from the ADAG study — the rate at which eAG changes per 1% change in A1C.

- 46.7: the intercept of the same regression line.

- 18.0182: the molecular weight conversion factor for glucose (g/mol divided by 10).

The formula comes from the A1C-Derived Average Glucose (ADAG) study published in Diabetes Care in 2008 by Nathan et al. The study enrolled 507 participants — 268 with type 1 diabetes, 159 with type 2 diabetes, and 80 non-diabetic adults — and measured both A1C and average glucose simultaneously over three months. Linear regression produced the 28.7 slope and 46.7 intercept used in all current ADA-endorsed A1C conversion tools.

A1C Calculator Worked Examples

Example1:Newly Diagnosed Adult — A1C 8.4%, Understanding the First Result

A 47-year-old man receives his first A1C result of 8.4% at a routine physical. He does not know what this means in terms of blood sugar and wants a clear picture before his follow-up appointment.

1. Formula: eAG = (28.7 x 8.4) - 46.7

2. Step 1: 28.7 x 8.4 = 241.08

3. Step 2: 241.08 - 46.7 = 194.38 mg/dL

4. Convert to mmol/L: 194.38 / 18.0182 = 10.8 mmol/L

5. IFCC equivalent: (8.4 - 2.15) / 0.0915 = 68 mmol/mol

6. ADA 2026 category: Diabetes (A1C 6.5% or higher)

7. ADA general target for adults 40 to 64: below 7.0% (154 mg/dL)

8. Gap to target: 8.4% - 7.0% = 1.4 percentage points above target

His eAG of 194 mg/dL means his blood sugar has averaged roughly 194 all day, every day for the past three months. The ADA general target for his age group is below 7.0% (154 mg/dL), placing him 1.4 percentage points above goal. A 1.4% A1C reduction is achievable with structured lifestyle changes — the Diabetes Prevention Program showed lifestyle intervention reduces progression risk by 58%. His physician will likely recommend dietary counseling and consider metformin as first-line medication while setting a 3-month recheck to track progress.

Example2:Well-Controlled Type 1 — A1C 6.2%, Verifying CGM Agreement

A 29-year-old woman with type 1 diabetes wears a continuous glucose monitor. Her CGM reports a 90-day average glucose of 131 mg/dL. Her lab A1C came back at 6.2%. She wants to verify the two numbers agree.

1. Reverse formula — convert CGM average to estimated A1C:

A1C = (131 + 46.7) / 28.7 = 177.7 / 28.7 = 6.19% — rounds to 6.2%

2. Forward formula — convert A1C 6.2% to eAG:

eAG = (28.7 x 6.2) - 46.7 = 177.94 - 46.7 = 131.24 mg/dL

3. Agreement: lab A1C and CGM average are in near-perfect agreement

4. ADA category: within diabetes-management range — below the diagnostic diabetes threshold of 6.5%

5. ADA target for adults under 40 without significant hypoglycemia: below 6.5% preferred

Her CGM and lab A1C agree within rounding, confirming accurate CGM calibration and consistent glucose control. At 6.2%, she is in excellent control — approaching the under-6.5% tight-control target the ADA endorses for younger adults without hypoglycemia risk. Her care team will focus on maintaining this level while monitoring for hypoglycemia, which becomes a greater risk as A1C approaches the 5s.

Example3:Prediabetes Range — A1C 6.1%, Reversible with Action

A 54-year-old woman receives an A1C of 6.1% at a health screening. She has no known diabetes diagnosis and wants to understand where she stands.

1. Formula: eAG = (28.7 x 6.1) - 46.7 = 175.07 - 46.7 = 128.37 mg/dL

2. mmol/L: 128.37 / 18.0182 = 7.1 mmol/L

3. ADA 2026 category: Prediabetes (A1C 5.7% to 6.4%)

4. Distance to diabetes threshold: 6.5% - 6.1% = 0.4 percentage points away from diabetes diagnosis

5. Distance back to normal: 6.1% - 5.7% = 0.4 percentage points above the normal upper limit

She sits in the middle of the prediabetes range — 0.4% away from both the normal boundary and the diabetes threshold. The CDC-recognized National Diabetes Prevention Program shows that lifestyle intervention (losing 5% to 7% of body weight and completing 150 minutes of moderate exercise weekly) reduces progression to type 2 diabetes by 58% — more effective than metformin alone (31%). At 6.1%, this is the most actionable result the calculator can return: still reversible, with a clear evidence-based path back to the normal range. Retest recommended in 6 to 12 months.

Example4:Older Adult with Relaxed Target — A1C 7.8%, Appropriate for Age Group

A 71-year-old man with type 2 diabetes and a history of hypoglycemia episodes has an A1C of 7.8%. His previous physician told him he needs to get below 7.0%. His new physician says 7.8% may be acceptable. He uses the calculator to understand both positions.

1. Formula: eAG = (28.7 x 7.8) - 46.7 = 223.86 - 46.7 = 177.16 mg/dL

2. mmol/L: 177.16 / 18.0182 = 9.8 mmol/L

3. ADA 2026 general target: below 7.0% (154 mg/dL)

4. ADA 2026 relaxed target for adults 65 and older with hypoglycemia risk: 7.5% to 8.0%

5. His result at 7.8%: within the ADA-endorsed relaxed target range for his age group

6. Standard target gap: 0.8 percentage points above 7.0%

7. Relaxed target assessment: within range — no target violation under ADA 2026 geriatric guidelines

His new physician is correct by the ADA 2026 Standards. For adults 65 and older with a history of hypoglycemia, functional limitations, or multiple comorbidities, the ADA explicitly endorses less stringent targets of 7.5% to 8.0%. Aggressive control to below 7.0% in this population increases the risk of hypoglycemia, which is more dangerous in older adults — associated with falls, cardiac events, and cognitive impairment. His 7.8% result is within the appropriate range for his profile. The most common misinterpretation in elderly diabetes care is applying a younger adult's target to an older patient without adjustment.

A1C Calculator Results What the Numbers Mean

The A1C result your calculator returns is a diagnostic classification and a clinical action signal — not just a number. Each range corresponds to a defined category with specific recommended responses under ADA 2026 Standards of Care.

A1C % | eAG (mg/dL) | eAG (mmol/L) | ADA 2026 Category | Recommended Action

Below 5.7% | Below 117 | Below 6.5 | Normal | Routine screening, maintain lifestyle

5.7% to 6.4% | 117 to 137 | 6.5 to 7.6 | Prediabetes | Lifestyle intervention, retest in 6-12 months

6.5% and above | 140 and above | 7.8 and above | Diabetes (diagnostic) | Confirm with second test, begin treatment

Below 7.0% | Below 154 | Below 8.6 | Diabetes — at goal (treated) | Maintain current regimen

7.0% to 8.0% | 154 to 183 | 8.6 to 10.2 | Diabetes — above goal | Review regimen, adjust medications or lifestyle

Above 9.0% | Above 212 | Above 11.8 | Poorly controlled | Prompt clinical review, medication change likely

10.0% and above | 240 and above | 13.3 and above | High risk | Urgent evaluation, insulin often indicated

Below 6.0% | Below 126 | Below 7.0 | Pregnancy target | Manage with obstetric team, tighter window

The most common misunderstanding is treating the diagnostic threshold of 6.5% as the treatment target for people already diagnosed with diabetes. These are two different numbers serving two different purposes. The 6.5% threshold is used to diagnose diabetes in someone who has not previously been diagnosed. The treatment target for most non-pregnant adults already managing diabetes is below 7.0% — not 6.5%. Conflating the two causes both unnecessary alarm in well-controlled patients and confusion about what the clinical goal actually is.

The second most common misunderstanding is thinking that a result close to a category boundary is equivalent to being in either the lower or higher category. A result of 6.4% is still prediabetes — not normal. A result of 6.5% meets the diagnostic criteria for diabetes on a single test but requires confirmation with a second test before a formal diagnosis is made, unless unambiguous hyperglycemia symptoms are present.

How Your Inputs Change the Result

A1C percentage is the only input that drives the eAG conversion — a 1% change in A1C always produces the same 28.7 mg/dL change in eAG, regardless of where on the scale you start. This linearity makes the clinical significance of small A1C changes easy to quantify.

A1C % | eAG (mg/dL) | eAG (mmol/L) | Category | Change per 0.5% Step (mg/dL)

5.0% | 97 | 5.4 | Normal | —

5.5% | 111 | 6.2 | Normal | +14.4

5.7% | 117 | 6.5 | Prediabetes threshold | +5.7

6.0% | 126 | 7.0 | Prediabetes | +8.6

6.5% | 140 | 7.8 | Diabetes threshold| +14.4

7.0% | 154 | 8.6 | ADA general target| +14.4

7.5% | 169 | 9.4 | Above target | +14.4

8.0% | 183 | 10.2 | Above target | +14.4

9.0% | 212 | 11.8 | Poorly controlled | +28.7

10.0% | 240 | 13.3 | High risk | +28.7

The 1% A1C reduction rule is one of the most cited statistics in diabetes management: each 1 percentage point reduction in A1C is associated with approximately a 35% reduction in risk of microvascular complications — neuropathy, retinopathy, and nephropathy — based on the landmark UKPDS trial data. This is why clinical guidelines focus on achievable A1C reductions rather than demanding immediate normalization. Moving from 8.0% to 7.0% cuts that complication risk by 35%. Moving from 9.0% to 8.0% cuts it by another 35%.

Age group selection changes the target interpretation without changing the eAG conversion. The same A1C of 7.8% produces different clinical guidance depending on the patient's age. For a 35-year-old, 7.8% is above the preferred tight-control target and warrants intensification. For a 72-year-old with hypoglycemia history, 7.8% falls within the ADA-endorsed relaxed target range. The conversion formula is identical — only the clinical interpretation changes with age.

Red blood cell conditions shift the real glucose level underlying a given A1C percentage. A patient with iron deficiency anemia may show a falsely elevated A1C because iron-deficient red blood cells glycate at a higher rate than normal cells. A patient with hemolytic anemia shows a falsely low A1C because red blood cells are destroyed before they accumulate the normal amount of glycation. In these populations, the eAG result from this calculator may not accurately reflect true average glucose — fructosamine testing or CGM time-in-range data are more appropriate.

A1C Calculator Common Mistakes to Avoid

- Using the diagnostic threshold of 6.5% as the treatment target. The 6.5% cutoff identifies diabetes in an undiagnosed person. The treatment goal for most managed diabetes patients is below 7.0%. Patients who are well-controlled at 6.7% sometimes think they are failing because they are "still diabetic" — this reflects a misunderstanding of what the two different numbers represent.

- Assuming one A1C test is sufficient for a diabetes diagnosis. The ADA requires two separate abnormal A1C tests on different days to confirm a new diabetes diagnosis, unless the patient has unambiguous hyperglycemia symptoms. A single 6.5% result triggers a repeat test — not an immediate diagnosis. Skipping the confirmation step leads to both false positives and inappropriate early treatment.

- Treating the ADAG eAG estimate as equivalent to a fingerstick reading. A1C-derived eAG is a mathematical estimate of the average blood glucose across 90 days. A single fingerstick reading at any given moment may be well above or below this average, depending on recent meals, activity, stress, and medication timing. The two measurements are not directly comparable on a moment-to-moment basis.

- Ignoring conditions that invalidate the A1C result. Sickle cell trait, thalassemia, G6PD deficiency, hemolytic anemia, and iron deficiency anemia all affect red blood cell lifespan or glycation rates in ways that make A1C inaccurate. A patient with sickle cell trait may have an A1C of 5.8% but a true average glucose that corresponds to 7.2%. If any hemoglobin variant condition is suspected, fasting plasma glucose or oral glucose tolerance testing is more reliable.

- Comparing A1C results from different laboratory methods without checking standardization. A1C can be measured by several different assay methods, not all of which are NGSP-certified or IFCC-aligned. A result from a non-certified home A1C kit may differ from a laboratory result by 0.3% to 0.7% — enough to change the diagnostic category at the boundaries. Always use NGSP-certified laboratory results for diagnostic purposes.

- Expecting A1C to reflect recent blood sugar changes. Because A1C reflects a 90-day weighted average, changes made in the last 2 to 4 weeks contribute only modestly to the current result. A patient who dramatically improved their diet last month will not see the full benefit in this quarter's A1C — it will appear more clearly in the next test 3 months later. This lag causes confusion and sometimes leads patients to question whether their efforts are working.

- Not accounting for pregnancy when interpreting A1C targets. Red blood cell turnover increases significantly during pregnancy, which can cause A1C to read 0.5% to 1.0% lower than it would in a non-pregnant state at the same average glucose. The ADA 2026 pregnancy target of below 6.0% is set tighter specifically because pregnancy physiology already tends to lower the measured A1C. Applying non-pregnancy targets to a pregnant patient underestimates the level of control required.

- Using A1C as the sole metric for diabetes management. A1C is a useful population-level tool but blind to glucose variability. Two people with identical A1C values of 7.5% may have completely different glucose profiles — one with stable blood sugar around 169 mg/dL all day, the other swinging between 60 and 300 mg/dL. The person with the swings faces higher risks from hypoglycemia and acute hyperglycemia despite the same A1C. Continuous glucose monitoring time-in-range complements A1C by capturing what the average cannot.

Key Terms Explained

A1C (HbA1c)

The percentage of hemoglobin in red blood cells with glucose attached, reflecting average blood sugar over the past 90 to 120 days. The standard clinical measure for diagnosing and monitoring diabetes in the United States.

eAG (Estimated Average Glucose)

A1C converted into mg/dL or mmol/L using the ADAG formula, making the lab result directly comparable to home glucose meter readings. Introduced by the ADA in 2008 to help patients connect lab reports to daily monitoring numbers.

ADAG Study

The A1C-Derived Average Glucose study, published in Diabetes Care in 2008 by Nathan et al. Enrolled 507 participants across type 1, type 2, and non-diabetic groups to derive the 28.7 slope and 46.7 intercept used in all current A1C conversion formulas.

NGSP

National Glycohemoglobin Standardization Program — the US certification system ensuring A1C tests are standardized across all certified laboratories. Values reported in percent (%). The standard format used in ADA guidelines and US clinical practice.

IFCC

International Federation of Clinical Chemistry — the international A1C standardization system, reporting values in mmol/mol. Used in the UK, much of Europe, and Australia. Converts to NGSP using: NGSP% = (0.0915 x IFCC) + 2.15.

Prediabetes

An A1C in the range of 5.7% to 6.4%, indicating blood sugar above normal but below the diabetes diagnostic threshold. Prediabetes is reversible through lifestyle changes in many cases. The ADA recommends retesting every 6 to 12 months and referral to a National Diabetes Prevention Program for eligible adults.

Time-in-Range (TIR)

The percentage of time CGM-measured glucose stays between 70 and 180 mg/dL, increasingly used alongside A1C to assess glycemic control. TIR captures glucose variability that A1C cannot — two patients with identical A1C values may have very different TIR profiles.

Glucose Management Indicator (GMI)

An A1C estimate calculated directly from CGM data using the formula: GMI = 3.31 + (0.02392 x mean glucose in mg/dL). GMI is not equivalent to lab A1C — it may be more accurate than lab A1C for individuals with hemoglobin variants or abnormal red blood cell physiology.

How This Calculator Works Methodology

This A1C calculator uses the ADAG formula as published in Nathan DM et al., Diabetes Care 2008;31(8):1473-1478: eAG (mg/dL) = (28.7 x A1C%) minus 46.7. This is the formula endorsed by the American Diabetes Association and reproduced at professional.diabetes.org.

Reverse conversion uses: A1C% = (eAG + 46.7) / 28.7. Unit conversion between mg/dL and mmol/L uses the exact molecular weight factor: 1 mg/dL = 0.05551 mmol/L (inverse: 1 mmol/L = 18.0182 mg/dL). IFCC to NGSP conversion uses the IFCC-NGSP master equation: NGSP% = (0.0915 x IFCC mmol/mol) + 2.15.

Diagnostic thresholds follow ADA Standards of Care in Diabetes — 2026, released December 8, 2025: normal below 5.7%, prediabetes 5.7% to 6.4%, diabetes at or above 6.5%. Treatment targets follow the same 2026 Standards: general adult target below 7.0%, tight-control target below 6.5% for appropriate younger adults, relaxed target 7.5% to 8.0% for adults 65 and older with hypoglycemia risk, and pregnancy target below 6.0%.

All results are rounded to one decimal place for A1C percentage and to the nearest whole number for eAG in mg/dL. mmol/L results are rounded to one decimal place. IFCC values are rounded to the nearest whole mmol/mol. This calculator is a planning and educational tool. Diabetes diagnosis requires NGSP-certified laboratory testing confirmed on two separate occasions.

Frequently Asked Questions About A1C Calculator

1. What is a normal A1C level?

According to ADA 2026 Standards of Care, a normal A1C is below 5.7%, corresponding to an estimated average glucose below 117 mg/dL. Values between 5.7% and 6.4% indicate prediabetes. An A1C of 6.5% or higher on two separate tests confirms a diabetes diagnosis. For adults already managing diabetes, the general treatment target is below 7.0% — a different number from the diagnostic threshold.

2. How do you convert A1C to average blood sugar?

Use the ADA-validated ADAG formula: eAG (mg/dL) equals (28.7 multiplied by A1C%) minus 46.7. For example, an A1C of 7.0% gives (28.7 x 7.0) minus 46.7 = 200.9 minus 46.7 = 154.2 mg/dL. To convert to mmol/L, divide by 18.0182: 154.2 / 18.0182 = 8.6 mmol/L. The reverse formula is: A1C% = (eAG + 46.7) / 28.7.

3. What A1C level is considered dangerous?

An A1C above 9% indicates poorly controlled diabetes with significantly elevated risk of microvascular complications. Above 10%, the ADA recommends urgent clinical evaluation and possible insulin initiation. At very high levels (above 12% to 14%), patients may experience classic hyperglycemia symptoms including extreme thirst, frequent urination, blurred vision, and fatigue, and are at risk of diabetic ketoacidosis in type 1 diabetes.

4. Does A1C differ between mg/dL and mmol/L countries?

The A1C percentage itself is the same worldwide under NGSP standardization. The difference is in how eAG is expressed: the US uses mg/dL while most other countries use mmol/L. One mg/dL equals 0.0555 mmol/L. An eAG of 154 mg/dL equals 8.6 mmol/L. The UK and Europe also use IFCC A1C units (mmol/mol) alongside percentages — 7.0% NGSP equals approximately 53 mmol/mol IFCC.

5. When should an A1C calculator not be used?

This calculator should not be used as the sole basis for a diabetes diagnosis — that requires a certified laboratory test confirmed on two occasions. It also produces inaccurate eAG estimates for people with hemoglobin variants, hemolytic anemia, iron deficiency, or pregnancy because these conditions alter red blood cell lifespan and glycation rates. In these situations, fasting plasma glucose or CGM time-in-range data are more reliable than A1C for assessing glucose control.

6. How do I get a more accurate A1C result?

For a clinical A1C, use an NGSP-certified laboratory — your doctor's office, hospital lab, or national laboratory network. Home A1C kits (such as A1CNow Self Check) provide results in 5 minutes from a finger-stick but have greater variability (plus or minus 0.5%) than certified lab tests. For the most accurate ongoing glucose picture, a CGM device worn for at least 14 days provides time-in-range data that complements A1C by showing glucose variability rather than just the average.

7. What does a typical A1C result look like for someone with well-controlled diabetes?

For most non-pregnant adults with type 2 diabetes managed with lifestyle and oral medication, a well-controlled A1C typically falls between 6.5% and 7.0% — an eAG of approximately 140 to 154 mg/dL. For younger adults with type 1 diabetes aiming for tighter control, values between 6.0% and 6.5% are common. For older adults with hypoglycemia risk, values between 7.5% and 8.0% are often appropriate per ADA 2026 geriatric guidelines.

8. Should I consult my doctor about my A1C result before changing medications?

Yes, always. The A1C calculator provides an accurate conversion and an ADA category classification — it does not constitute medical advice or authorize medication changes. Any change to diabetes medications, including dose adjustments, additions, or discontinuations, must be made in consultation with a licensed healthcare provider. If your A1C is above 9% or you are experiencing symptoms of high blood sugar, contact your provider promptly rather than waiting for your next scheduled appointment.

Related Calculators Worth Bookmarking

- Blood Sugar Level Checker — interprets fasting, post-meal, and random glucose readings against ADA reference ranges, the daily monitoring companion to the quarterly A1C snapshot.

- Type 2 Diabetes Risk Calculator — estimates 10-year diabetes risk using the ADA risk score based on age, weight, family history, activity level, and blood pressure, useful for adults in the prediabetes range.

- BMI Calculator — body mass index is a key modifiable risk factor for type 2 diabetes; pairing A1C results with BMI gives a more complete metabolic risk picture.

- Calorie Calculator — estimates daily energy needs for weight management, a central lifestyle intervention for both prediabetes reversal and diabetes management.

- Cholesterol Risk Calculator — cardiovascular risk is the leading cause of death in adults with diabetes; A1C and lipid panel together define the full cardiometabolic risk profile.

- Insulin Dose Calculator — estimates correction and carbohydrate-coverage insulin doses based on blood glucose, carb intake, and insulin sensitivity — for reference use only under physician guidance.

References and Further Reading

1. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1C assay into estimated average glucose values. Diabetes Care. 2008;31(8):1473-1478.

2. American Diabetes Association Professional Practice Committee. Standards of Care in Diabetes — 2026. Diabetes Care. 2026;49(Supplement 1). Released December 8, 2025.

3. American Diabetes Association. eAG/A1C Conversion Calculator. professional.diabetes.org. Accessed April 2026.

4. Centers for Disease Control and Prevention. All About Your A1C. cdc.gov/diabetes. Updated 2024.

5. National Institute of Diabetes and Digestive and Kidney Diseases. The A1C Test and Diabetes. niddk.nih.gov. Updated September 2023.

6. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837-853.

Important Disclaimer

This A1C calculator is provided for informational and educational purposes only. Results are mathematical estimates based on the ADAG formula and ADA 2026 clinical guidelines. This tool does not constitute medical advice, diagnosis, or treatment. A diabetes diagnosis requires a certified laboratory A1C test confirmed on two separate occasions, or combined with a fasting plasma glucose or oral glucose tolerance test. Never use a calculated eAG estimate to self-diagnose diabetes or to adjust medications without consulting a licensed healthcare provider. If your A1C result is above 9% or you are experiencing symptoms of high blood sugar, contact your physician promptly.